Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy after pelvic irradiation in patients with cervical cancer: a retrospective study with radiography-based dosimetry.
Huang EY, Wang CJ, Lan JH, Chen HC, Fang FM, Hsu HC, Huang YJ, Wang CY, Wang YM. Huang EY, et al. Among authors: huang yj. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):490-5. doi: 10.1016/j.ijrobp.2009.02.018. Epub 2009 May 19. Int J Radiat Oncol Biol Phys. 2010. PMID: 19467795
Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ. Huang EY, et al. Among authors: huang yj. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1105-13. doi: 10.1016/j.ijrobp.2010.07.011. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932670
Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY, Huang YJ, Chanchien CC, Lin H, Wang CJ, Sun LM, Tseng CW, Tsai CC, Ou YC, Fu HC, Chen HC, Hsu HC, Wang CY. Huang EY, et al. Among authors: huang yj. Radiat Oncol. 2012 Jan 30;7:13. doi: 10.1186/1748-717X-7-13. Radiat Oncol. 2012. PMID: 22289572 Free PMC article.
Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH, Huang TL, Chien CY, Chen HC, Hsu HC, Huang EY, Wang CJ, Huang YJ, Wang YM, Huang CC, Chou SY, Liao KC, Fang FM. Lin YH, et al. Among authors: huang ey, huang yj, huang cc, huang tl. Radiat Oncol. 2018 Mar 20;13(1):45. doi: 10.1186/s13014-018-0990-5. Radiat Oncol. 2018. PMID: 29554940 Free PMC article.
Optimal treatments for cervical adenocarcinoma.
Wu SY, Huang EY, Lin H. Wu SY, et al. Among authors: huang ey. Am J Cancer Res. 2019 Jun 1;9(6):1224-1234. eCollection 2019. Am J Cancer Res. 2019. PMID: 31285954 Free PMC article.
388 results